Page last updated: 2024-09-04

vatalanib and Carcinoma

vatalanib has been researched along with Carcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broggini-Tenzer, A; Jochum, W; Oehler-Jänne, C; Pruschy, M; Riesterer, O; Vuong, V1
Barber, SE; Bekele, BN; Jasser, SA; Kim, S; Mandal, M; Myers, JN; Yazici, YD1
Ametamey, S; Honer, M; Jochum, W; Oehler, C; Pruschy, M; Riesterer, O1
Arevalo, JM; Armaiz-Pena, G; Bankson, JA; Cole, SW; Coleman, RL; Felix, E; Gershenson, DM; Han, LY; Jennings, NB; Kamat, AA; Kim, TJ; Kundra, V; Landen, CN; Li, Y; Lin, YG; Lloyd, M; Lopez-Berestein, G; Lu, C; Lutgendorf, SK; Mangala, LS; Merritt, WM; Newman, RA; Ravoori, M; Sanguino, AM; Sood, AK; Takahashi, R; Thaker, PH1
Bold, G; Buchdunger, E; Cozens, R; Drevs, J; Ferrari, S; Frei, J; Hofmann, F; Martiny-Baron, G; Menrad, A; Mestan, J; Mett, H; O'Reilly, T; Persohn, E; Rösel, J; Schirner, M; Schneider, MR; Schnell, C; Siemeister, G; Stover, D; Theuer, A; Thierauch, KH; Totzke, F; Towbin, H; Wenger, F; Wood, JM; Woods-Cook, K1

Other Studies

5 other study(ies) available for vatalanib and Carcinoma

ArticleYear
Ionizing radiation and inhibition of angiogenesis in a spontaneous mammary carcinoma and in a syngenic heterotopic allograft tumor model: a comparative study.
    Radiation oncology (London, England), 2011, Jun-08, Volume: 6

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma; Female; Humans; Male; Mammary Neoplasms, Animal; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Pyridines; Radiation, Ionizing; Receptors, Vascular Endothelial Growth Factor; Transplantation, Homologous

2011
Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.
    Head & neck, 2006, Volume: 28, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Irinotecan; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Thyroid Neoplasms

2006
Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jun-01, Volume: 12, Issue:11 Pt 1

    Topics: Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Glucose Transporter Type 1; Humans; Immunohistochemistry; Mammary Neoplasms, Animal; Mice; Misonidazole; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Positron-Emission Tomography; Pyridines; Transplantation, Homologous

2006
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
    Nature medicine, 2006, Volume: 12, Issue:8

    Topics: Animals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; Female; Humans; Isoproterenol; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Organ Size; Ovarian Neoplasms; Phthalazines; Pyridines; Radiography; Random Allocation; Stress, Psychological; Terbutaline; Transplantation, Heterologous; Tumor Burden; Vascular Endothelial Growth Factor A

2006
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Cancer research, 2000, Apr-15, Volume: 60, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Cells; Carcinoma; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Hematopoiesis; Humans; Kidney Neoplasms; Leukocytes; Lymphokines; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphorylation; Phthalazines; Platelet-Derived Growth Factor; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wound Healing

2000